Tocqueville Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-28,600
| Closed | -$327K | – | 886 |
|
|
2016
Q3 | $327K | Hold |
28,600
| – | – | ﹤0.01% | 696 |
|
|
2016
Q2 | $352K | Sell |
28,600
-2,600
| -8% | -$32K | ﹤0.01% | 695 |
|
|
2016
Q1 | $315K | Sell |
31,200
-26,050
| -46% | -$263K | ﹤0.01% | 719 |
|
|
2015
Q4 | $1.29M | Buy |
57,250
+21,400
| +60% | +$482K | 0.02% | 496 |
|
|
2015
Q3 | $595K | Sell |
35,850
-5,400
| -13% | -$89.6K | 0.01% | 657 |
|
|
2015
Q2 | $928K | Sell |
41,250
-2,100
| -5% | -$47.2K | 0.01% | 585 |
|
|
2015
Q1 | $1.12M | Hold |
43,350
| – | – | 0.01% | 569 |
|
|
2014
Q4 | $943K | Buy |
43,350
+1,000
| +2% | +$21.8K | 0.01% | 594 |
|
|
2014
Q3 | $802K | Sell |
42,350
-800
| -2% | -$15.2K | 0.01% | 536 |
|
|
2014
Q2 | $1.01M | Buy |
43,150
+17,250
| +67% | +$402K | 0.01% | 575 |
|
|
2014
Q1 | $872K | Buy |
25,900
+16,500
| +176% | +$556K | 0.01% | 472 |
|
|
2013
Q4 | $277K | Buy |
+9,400
| New | +$277K | ﹤0.01% | 729 |
|